ok-1244: Oklahoma Health Care Authority — Medical Providers-Fee for Service
Public comment closed .
Get alerted when the next rule lands
New rules open for comment on their own schedule. Pick how you want to hear about them — we email you when one appears.
Publishing to members? Embed a live rule tracker on your own site — the proposed rules in your area and the comment deadlines closing on them, updating themselves. Free, one line of HTML.
Create a free account & build one →Summary
he proposed revisions seek to remove certain drugs and therapies from the 340b Drug Pricing Program. The 340b program is a federal initiative that allows health care organizations to purchase certain drugs at a discount direct from pharmaceutical manufacturers. One restriction on this program is that no rebates can be collected from any drug or therapy purchased under the program, including supplemental rebates. These revisions would prohibit purchasing drugs which are in a supplemental rebate agreement from being purchased under the 340b program.
The agency’s own summary, as published.
Don't miss the comment window
One Click Politics alerts you on every deadline, hearing, and rule change.
See all rules with comments due soon →